Neutral
●
GlobeNewsWire
●
5 months ago
SOUTH SAN FRANCISCO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on April 15, 2026 it granted stock options to purchase an aggregate of 49,358 shares of common stock and 32,734 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting to 33 employees, whose employment commenced in March and April 2026 ...